Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood
Advanced Healthcare Materials · 2026-08 · 15 (30)
DOI: 10.1002/adhm.71408 ↗At a glance
Journal article in Advanced Healthcare Materials, published online on 2026-07-03. Written by Beibei Lu and 6 co-authors. Institution: State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China. Major MEDLINE topics: Smartphone, Myocardial Infarction, Biosensing Techniques, Biomarkers. 42 references. The full text is freely available in PubMed Central. Funded by: Sichuan Science and Technology Program, Natural Science Foundation of Chongqing, China.
Abstract (original language)
Acute myocardial infarction (AMI) requires rapid diagnosis beyond conventional methods, which suffer from biological interference and complexity, limiting point‐of‐care (POC) application. To tackle these issues, we have devised an anthraquinone (AQ)‐calibrated sensor unit coupled with smartphone‐based analysis for universal detection of AMI biomarkers in untreated whole blood. Our novel dual‐channel biosensing platform integrates AQ as an intrinsic reference standard, establishing a self‐correction mechanism to effectively counteract hematological matrix influences. The platform enables swift quantification at pg/mL levels within 5 min without sample preprocessing, achieving detection limits of 0.3, 19.7, and 0.7 pg/mL for cTnI, Mb, and CK‑MB, respectively. The smartphone‑based intelligent analyzer automates real‐time signal processing, creating a closed‐loop POC diagnostic setup that shows promise for future at‑home AMI risk monitoring. This technological breakthrough showcases notable resilience to biological matrix interference while upholding analytical sensitivity comparable to clinical standards, representing a significant step toward decentralized cardiovascular emergency management.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory of Resource Insects, College of Sericulture, Textile and Biomass Sciences, Southwest University, Chongqing, China.
- College of Pharmaceutical Sciences, Southwest University, Chongqing, China.
- College of Engineering and Technology, Southwest University, Chongqing, China.
- Department of Cardiology, The Sixth People's Hospital of Huizhou, Guangdong, China.
Funding
- Sichuan Science and Technology Program
- Natural Science Foundation of Chongqing, China
Cite
APA
Lu, B., Gong, H., Huang, H., Fang, K., Yu, K., Lu, B., & Lan, G. (2026). Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood. Advanced Healthcare Materials, 15(30). https://doi.org/10.1002/adhm.71408
Vancouver
Lu B, Gong H, Huang H, Fang K, Yu K, Lu B, et al. Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood. Advanced Healthcare Materials. 2026;15(30). doi:10.1002/adhm.71408
BibTeX
@article{Lu2026,
author = {Lu, Beibei and Gong, Huaibin and Huang, Hua and Fang, Kuaifa and Yu, Kun and Lu, Bitao and Lan, Guangqian},
title = {Smartphone‐Enabled Point‐of‐Care Biosensing Platform With Self‐Calibration for Rapid Matrix‐Resistant Detection of Multiple AMI Biomarkers in Whole Blood},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {30},
doi = {10.1002/adhm.71408}
}
EUVIMED